On Thursday, December 19, Washington University’s John T. Milliken Department of Medicine hosted their Medicine Grand Rounds event series at the Clopton Auditorium. During which the first-ever Repa-Eschen Lecture took place with presenting speaker Clay F. Semenkovich, MD, Chief of the Division of Endocrinology, Metabolism and Lipid Research, Irene E. and Michael M. Karl Professor of […]
Tag: clay semenkovich
Understanding muscle insulin resistance in metabolic syndrome
In March, Samantha Adamson, MD, PhD; Sangeeta Adak, PhD; Max C. Petersen, MD, PhD; Dustin Higgins, DO; Larry D. Spears, PhD; Rong Mei Zhang, MD; Andrea Cedeno, MD; Alexis McKee, MD, CDCES; Aswathi Kumar, MD; Sudhir M. Singh, MD; Fong-Fu Hsu, PhD; Janet B. McGill, MD, MA, FACP; and Clay F. Semenkovich, MD had their […]
Semenkovich describes model of type 2 diabetes in video series for World Diabetes Day
On November 14, Dr. Clay F. Semenkovich, Chief of the Division of Endocrinology, Metabolism and Lipid Research, participated in World Diabetes Day by joining in a YouTube series hosted by Cell Metabolism. In the series, Dr. Semenkovich discusses the paper “Palmitoylation couples insulin hypersecretion with β cell failure in diabetes,” published on February 7, 2023, […]
2023 Castle Connolly Top Doctors® (Links to an external site)
Protein palmitoylation helps to model the evolution of some forms of type 2 diabetes
On February 7, Guifang Dong, PhD; Sangeeta Adak, PhD; Qiang Zhang, PhD; Chu Feng, MS; Li Yin, MD; Sarah Speck; Shuntaro Morikawa; Rie Asada, PhD; Fumihiko Urano, MD, PhD; Maria Remedi, PhD; Xiaochao Wei, PhD; Clay Semenkovich, MD; and collaborators had their work published in “Cell Metabolism.” “Hyperinsulinemia often precedes type 2 diabetes,” and palmitoylation, […]
Semenkovich Lab and collaborators show the evolution of type 2 diabetes through APT1 deficiency
On January 11, Semenkovich Lab and collaborators, had their research titled “Palmitoylation couples insulin hypersecretion with β cell failure in diabetes,” published in “Cell Metabolism.” Hyperinsulinemia is known to often come before type 2 diabetes. In the study, they explain how acyl-protein thioesterase 1 (APT1) knockdown in nondiabetic islets causes insulin hypersecretion. By using palmitoylation proteomics, their […]
Semenkovich publishes research on mechanisms to improve targeted atherosclerosis therapy
On June 15, Clay F. Semenkovich, MD and collaborators had their research titled “Altered Peroxisome Proliferator-Activated Receptor Alpha Signaling in Variably Diseased Peripheral Arterial Segments,” published in “Frontiers in Cardiovascular Medicine.” “Peripheral atherosclerosis that accumulates in the extracranial carotid and lower extremity arteries can lead to significant morbidity and mortality. However, atherosclerotic disease progression is […]